Battlefield pain summit 2022: Expert consensus statements
- PMID: 35667094
- DOI: 10.1097/TA.0000000000003711
Battlefield pain summit 2022: Expert consensus statements
Abstract
Background: Battlefield pain occurs in combat casualties who experience multiple severe injuries. The nature of battlefield scenarios requires a distinct approach to battlefield pain research. A battlefield pain summit was thus convened to identify shortcomings in the current understanding of battlefield pain management, review the current state of battlefield pain research, and shape the direction of future research.
Methods: On January 10 to 11, 2022, a hybrid in-person and virtual meeting hosted by the US Army Institute of Surgical Research defined research priorities for the Combat Casualty Care Research Program's Battlefield Pain research portfolio. Summit participants identified the following key focus areas under the umbrella of battlefield pain research: battlefield injury patterns; use of ketamine and nonopioid analgesics; analgesic delivery systems; the impact of analgesia on performance, cognition, and survival; training methods; battlefield regional anesthesia; and research models. Preliminary statements presented during the summit were refined and rank ordered through a Delphi process.
Results: Consensus was achieved on 7 statements addressing ideal analgesic properties, delivery systems, operational performance concerns, and pain training. Ketamine was identified as safe and effective for battlefield use, and further research into nonopioid analgesics represented a high priority.
Conclusion: The 7 consensus statements that emerged from this battlefield pain summit serve as a template to define the near-term research priorities for military-specific battlefield pain research.
Copyright © 2022 Written work prepared by employees of the Federal Government as part of their official duties is, under the U.S. Copyright Act, a “work of the United States Government” for which copyright protection under Title 17 of the United States Code is not available. As such, copyright does not extend to the contributions of employees of the Federal Government.
References
-
- Mazuchowski EL, Kotwal RS, Janak JC, Howard JT, Harcke HT, Montgomery HR, et al. Mortality review of US Special Operations Command battle-injured fatalities. J Trauma Acute Care Surg . 2020;88:686–695.
-
- Blackbourne LH, Baer DG, Cestero RF, Inaba K, Rasmussen TE. Exsanguination shock: the next frontier in prevention of battlefield mortality. J Trauma . 2011;71(Suppl):S1–S3.
-
- Cap AP, Polk TM, Cannon JW. Charting a new path after two decades of war and a global pandemic. J Trauma Acute Care Surg . 2021;91(Suppl 2):S1–S5.
-
- Clifford JL, Fowler M, Hansen JJ, Cheppudira B, Nyland JE, Salas MM, et al. State of the science review: advances in pain management in wounded service members over a decade of war. J Trauma Acute Care Surg . 2014;77(Suppl 2):S228–S236.
-
- Kim SY, Buckenmaier CC, Howe EG, Choi KH. The newest battlefield opioid, sublingual sufentanil: a proposal to refine opioid usage in the U.S. Military. Mil Med . 2022;187:77–83.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical